Transporter genesABCG2rs2231142 andABCB1rs1128503 polymorphisms and atorvastatin response in Chilean subjects-Reference-Cited by-同舟云学术

Transporter genesABCG2rs2231142 andABCB1rs1128503 polymorphisms and atorvastatin response in Chilean subjects

Published:2017-08-19 Issue:1 Volume:43 Page:87-91
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Prado Y.¹,Zambrano T.¹,Salazar L. A.¹

Affiliation:

1. Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus (BIOREN); Universidad de La Frontera; Temuco Chile

Funder

Fondo Nacional de Desarrollo Científico y Tecnológico

Comisión Nacional de Investigación Científica y Tecnológica

Universidad de La Frontera

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12607/fullpdf

Reference30 articles.

1. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks;Minder;Curr Opin Cardiol,2013

2. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor;Brown;Cell,1997

3. The evolving role of statins in the management of atherosclerosis;Vaughan;J Am Coll Cardiol,2000

4. Transporter pharmacogenetics and statin toxicity;Niemi;Clin Pharmacol Ther,2010

5. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs;Rodrigues;Pharmacogenomics,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between genetic polymorphisms and other attributing factors with lipid profiles among statin users: a cross-sectional retrospective study;Egyptian Journal of Medical Human Genetics;2024-04-16

2. Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy;Clinical Biochemistry;2024-02

3. Correlation between ABCB1 and OLIG2 polymorphisms and the severity and prognosis of patients with cerebral infarction;Open Medicine;2024-01-01

4. The ABCB1 C3435T Polymorphism is Associated with Triglyceride Reduction in Atorvastatin-treated Uygur Patients with Coronary Heart Disease and Dyslipidemia: An Observational Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-08

5. Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease;Frontiers in Pharmacology;2023-02-27